您当前的位置：
首页 >
文章列表页 >
Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma
Short communication | 更新时间：2024-02-04

    • Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma

    • Genes & Diseases   Vol. 11, Issue 2, (2024)
    • 作者机构：

      1. Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital,Jiangsu,Nanjing,China,210029

      2. Collaborative Innovation Center for Cancer Personalized Medicine,Jiangsu,Nanjing,China,210029

      3. Key Laboratory of Hematology of Nanjing Medical University,Jiangsu,Nanjing,China,210029

    • DOI：10.1016/j.gendis.2023.04.012    

      CLC：

    • Published：2024，

      Published Online：1 March 2024，

    扫 描 看 全 文

  • Jing Tang, Yue Li, Jiazhu Wu, et al. Bortezomib depended on PRDM1 and TP53 to exert therapeutic effect in activated B-cell-like diffuse large B-cell lymphoma. [J]. Genes & Diseases 11(2).(2024) DOI： 10.1016/j.gendis.2023.04.012.

  •  
  •  
查看原文

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0